Medovate is truly a market first, working with a number of partners to develop our outstanding medical technologies.

 Leeds Final

The Leeds Teaching Hospitals NHS Trust

Leeds Teaching Hospitals NHS Trust is one of the largest and busiest acute hospital trusts in the UK. Medovate is working with Leeds Teaching Hospitals to develop RADS, (Regional Anaesthesia Delivery System).

Visit Website

The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust

Providing a comprehensive range of specialist, acute, obstetrics and community-based services. Medovate is working with The Queen Elizabeth Hospital to develop SAFIRA, (Safer Injection For Regional Anaesthesia).

Visit Website

Health Enterprise East

Delivering technology advisory services and innovation management to industry and the NHS. Medovate works with HEE to identify new NHS created medical technology opportunities.

Visit Website

NVM Private Equity LLP

Independently owned with over 30 years’ experience of investing in unquoted UK businesses. NVM is an investor shareholder in Medovate.

Visit Website
 Medtech Accelerator

Medtech Accelerator

Facilitating early stage development of medtech innovations that meet unmet clinical needs within the NHS. Medovate works with the MTA to identify new medical technology opportunities.

Visit Website


MedXPress.Pro is a manufacturer of medical products and educational tools with a focus on ultrasound-guided diagnostics and interventional procedures.

Visit Website

Eastern Academic Health Science Network

Bringing together health services, industry, and academia to drive economic growth, improve health and bring new approaches to healthcare.

Visit Website

Register Interest

Medovate is an innovation development company dedicated to bringing novel medical technologies to market.